(1beta,2beta)-17-(Acetyloxy)-1,2-dihydro-3'H-cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione

Bicalutamide is an antiandrogen compound used as an active pharmaceutical ingredient in medications primarily for prostate cancer. It is typically employed in combination with gonadotropin-releasing hormone analogues or surgical castration in advanced stages of the disease.